首页> 外文期刊>The journal of clinical endocrinology and metabolism >A Novel Point Mutation in the DNA-Binding Domain (DBD) of the Human Glucocorticoid Receptor Causes Primary Generalized Glucocorticoid Resistance by Disrupting the Hydrophobic Structure of its DBD
【24h】

A Novel Point Mutation in the DNA-Binding Domain (DBD) of the Human Glucocorticoid Receptor Causes Primary Generalized Glucocorticoid Resistance by Disrupting the Hydrophobic Structure of its DBD

机译:人类糖皮质激素受体的DNA结合域(DBD)中的新型点突变通过破坏其DBD的疏水结构,导致主要的广义糖皮质激素抵抗。

获取原文
           

摘要

Context:Primary generalized glucocorticoid resistance is a rare genetic condition characterized by partial end-organ insensitivity to glucocorticoids. Most affected subjects present with clinical manifestations of mineralocorticoid and androgen excess. The condition has been associated with inactivating mutations in the human glucocorticoid receptor (hGR) gene, which impair the molecular mechanisms of hGRα action, thereby reducing tissue sensitivity to glucocorticoids.
机译:背景:原发性广义糖皮质激素抵抗是一种罕见的遗传病,其特征是末端器官对糖皮质激素不敏感。大多数受影响的受试者表现出盐皮质激素和雄激素过多的临床表现。该病与人类糖皮质激素受体(hGR)基因的失活突变有关,后者会破坏hGRα作用的分子机制,从而降低组织对糖皮质激素的敏感性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号